EXOGENOUS BUT NOT ENDOGENOUS EBV INDUCES LYMPHOMAS IN BEIGE NUDE XID MICE CARRYING HUMAN LYMPHOID XENOGRAFTS

被引:10
作者
DOSCH, HM [1 ]
COCHRANE, DMG
COOK, VA
LEEDER, JS
CHEUNG, RK
机构
[1] UNIV TORONTO, HOSP SICK CHILDREN,RES INST,DEPT PEDIAT, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA
[2] UNIV TORONTO, HOSP SICK CHILDREN, RES INST, DEPT IMMUNOL, TORONTO M5G 1X8, ONTARIO, CANADA
关键词
EBV; LYMPHOMA; HUMAN XENOGRAFTS; IMMUNODEFICIENCY;
D O I
10.1093/intimm/3.7.731
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV) is a latent human herpes virus that growth-transforms EBV receptor/CD21+ B cells and is associated with several high-frequency malignancies. Reactivation of latent EBV occurs in approximately 1/3 of organ graph recipients and a majority of AIDS patients; EBV-positive B lymphoproliferative lesions represent often fatal complications in organ transplantation and late-stage AIDS. Although such lymphomas can arise from endogenous virus, the high tumor risk in EBV-seronegative transplant recipients implies de novo infection, in particular virus transmission with intra-graft B lymphocytes. Since SCID mice engrafted with human lymphocytes (SCID(hum)) typically develop endogenous EBV+ (human) tumors in their graft it is difficult to study exogenous virus transmission in this model. We here demonstrate that beige/nude/xid mice engrafted with human lymphoid cells (BNX(hum)) selectively accept human B but not T cell grafts. Unexpectedly these mice fail to develop endogenous lymphomas observed in SCID(hum) mice engrafted in parallel. However, injection of as few as < 500 EBV particles produces rapidly fatal, polyclonal lymphomas in BNX(hum) animals. This virus sensitivity of BNX(hum) approaches conditions for EBV transmission with organ grafts.
引用
收藏
页码:731 / 735
页数:5
相关论文
共 32 条
  • [1] DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME
    BAER, R
    BANKIER, AT
    BIGGIN, MD
    DEININGER, PL
    FARRELL, PJ
    GIBSON, TJ
    HATFULL, G
    HUDSON, GS
    SATCHWELL, SC
    SEGUIN, C
    TUFFNELL, PS
    BARRELL, BG
    [J]. NATURE, 1984, 310 (5974) : 207 - 211
  • [2] BRUSAMOLINO E, 1989, HAEMATOLOGICA, V74, P605
  • [3] EPSTEIN-BARR-VIRUS INDUCES AGGRESSIVE LYMPHOPROLIFERATIVE DISORDERS OF HUMAN B-CELL ORIGIN IN SCID/HU CHIMERIC MICE
    CANNON, MJ
    PISA, P
    FOX, RI
    COOPER, NR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1333 - 1337
  • [4] CLEARY ML, 1988, BLOOD, V72, P349
  • [5] DAVEY DD, 1989, MODERN PATHOL, V2, P27
  • [6] DOSCH HM, 1989, J IMMUNOL, V143, P2464
  • [7] DOSCH HM, 1985, J IMMUNOL, V134, P336
  • [8] EBV UTILIZES A UNIQUE ACTIVATION PATHWAY FOR THE TRANSFORMATION OF HUMAN B-CELLS
    DOSCH, HM
    LAM, P
    HUI, MF
    HIBI, T
    CHEUNG, RK
    [J]. INTERNATIONAL IMMUNOLOGY, 1990, 2 (09) : 833 - 848
  • [9] EPSTEIN-BARR-VIRUS-RELATED MALIGNANT B-CELL LYMPHOPLASMACYTIC LYMPHOMA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA
    FORMAN, SJ
    SULLIVAN, JL
    WRIGHT, C
    RATECH, H
    RACKLIN, B
    BLUME, KG
    [J]. TRANSPLANTATION, 1987, 44 (02) : 244 - 249
  • [10] FULOP GM, 1989, J EXP MED, V170, P1427